4RY:FRA
Akeso Inc
€10.32
arrow_upward
+1.18%(+0.12) 1D
Oct 20, 3:25:01 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4RY...
Open
€10.31
High
€10.32
Low
€10.30
Mkt. cap
86.02B
Avg. vol.
274.00
Volume
0.00
52-wk high
€16.41
52-wk low
€9.16
No. of employees
4K
Open
€10.31
High
€10.32
Low
€10.30
Mkt. cap
86.02B
Avg. vol.
274.00
Volume
0.00
52-wk high
€16.41
52-wk low
€9.16
No. of employees
4K
News stories
From web sources and news partners
Yahoo Finance
·
2 days ago
Will Phase III Colon Cancer Trial Change Akeso Stock Narrative
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees4.08K
FoundedMar 19, 2012
Headquarters-
SectorBiotechnology
Websiteakesobio.com